| Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial DR Anderson, SR Kahn, MA Rodger, MJ Kovacs, T Morris, A Hirsch, ... Jama 298 (23), 2743-2753, 2007 | 715 | 2007 |
| How effective are disease-modifying drugs in delaying progression in relapsing-onset MS? MG Brown, S Kirby, C Skedgel, JD Fisk, TJ Murray, V Bhan, IS Sketris Neurology 69 (15), 1498-1507, 2007 | 99 | 2007 |
| Considerations and costs of disclosing study findings to research participants CV Fernandez, C Skedgel, C Weijer Cmaj 170 (9), 1417-1419, 2004 | 94 | 2004 |
| Hospital-based psychiatric service utilization and morbidity in multiple sclerosis JD Fisk, SA Morehouse, MG Brown, C Skedgel, TJ Murray Canadian journal of neurological sciences 25 (3), 230-235, 1998 | 71 | 1998 |
| An incremental cost analysis of telehealth in Nova Scotia from a societal perspective DD Persaud, S Jreige, C Skedgel, J Finley, J Sargeant, N Hanlon Journal of Telemedicine and Telecare 11 (2), 77-84, 2005 | 69 | 2005 |
| Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer NWD Lamond, C Skedgel, D Rayson, L Lethbridge, T Younis Breast cancer research and treatment 133, 1115-1123, 2012 | 63 | 2012 |
| Gout in the elderly—a population health study JG Hanly, C Skedgel, I Sketris, C Cooke, T Linehan, K Thompson, ... The Journal of Rheumatology 36 (4), 822-830, 2009 | 63 | 2009 |
| Societal preferences for distributive justice in the allocation of health care resources: a latent class discrete choice experiment C Skedgel, A Wailoo, R Akehurst Medical Decision Making 35 (1), 94-105, 2015 | 59 | 2015 |
| The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada A Drucker, C Skedgel, K Virik, D Rayson, M Sellon, T Younis Current oncology 15 (3), 136-142, 2008 | 58 | 2008 |
| Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital HL Neville, B Chevalier, C Daley, L Nodwell, C Harding, A Hiltz, ... International Journal of Pharmacy Practice 22 (3), 216-222, 2014 | 56 | 2014 |
| The cost of treating diabetic ketoacidosis in the UK: a national survey of hospital resource use KK Dhatariya, C Skedgel, R Fordham Diabetic Medicine 34 (10), 1361-1366, 2017 | 55 | 2017 |
| Cost-effectiveness of interferon beta-1b in slowing multiple sclerosis disability progression: first estimates MG Brown, TJ Murray, IS Sketris, JD Fisk, JC LeBlanc, CE Schwartz, ... International Journal of Technology Assessment in Health Care 16 (03), 751-767, 2000 | 53 | 2000 |
| The relative importance of clinical, economic, patient values and feasibility criteria in cancer drug reimbursement in Canada: a revealed preferences analysis of … C Skedgel, D Wranik, M Hu Pharmacoeconomics 36, 467-475, 2018 | 48 | 2018 |
| The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty C Skedgel, R Goeree, S Pleasance, K Thompson, B O'brien, D Anderson JBJS 89 (4), 819-828, 2007 | 45 | 2007 |
| Choosing vs. allocating: discrete choice experiments and constant‐sum paired comparisons for the elicitation of societal preferences CD Skedgel, AJ Wailoo, RL Akehurst Health Expectations 18 (5), 1227-1240, 2015 | 43 | 2015 |
| The cost‐utility of sequential adjuvant trastuzumab in women with Her2/Neu‐positive breast cancer: An analysis based on updated results from the HERA Trial C Skedgel, D Rayson, T Younis Value in Health 12 (5), 641-648, 2009 | 43 | 2009 |
| Simultaneous liver kidney transplantation: a medical decision analysis B Kiberd, C Skedgel, I Alwayn, K Peltekian Transplantation 91 (1), 121-127, 2011 | 40 | 2011 |
| Identification of patients with systemic lupus erythematosus in administrative healthcare databases JG Hanly, K Thompson, C Skedgel Lupus 23 (13), 1377-1382, 2014 | 38 | 2014 |
| The cost–utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer T Younis, D Rayson, C Skedgel Current Oncology 18 (6), 288-296, 2011 | 37 | 2011 |
| Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole C Skedgel, D Rayson, R Dewar, T Younis Breast cancer research and treatment 101, 325-333, 2007 | 36 | 2007 |
Tallal YounisDalhousie UniversityVerified email at nshealth.ca
